Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Cloudera, AMC rise; Johnson & Johnson, Abbott fall

06/01/2021 | 04:17pm EDT

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Tuesday:

Quanta Services Inc., up $1.10 to $96.45.

The infrastructure company's Luma Energy joint venture with Canadian Utilities Limited started operating Puerto Rico's power grid.

American Financial Group Inc., up $1.58 to $134.64.

The insurance company declared a one-time special dividend of $14 per share.

Cloudera Inc., up $3.07 to $15.93.

The data management and software company is being bought by affiliates of Clayton, Dubilier & Rice for about $5.3 billion.

Abbott Laboratories, down $10.86 to $105.79.

The medical device and diagnostics company cut its financial forecast for the year on lower demand for COVID-19 tests.

Johnson & Johnson, down $3.72 to $165.53.

The Supreme Court is leaving in place a $2 billion verdict in favor of women who claim they developed ovarian cancer from using the health care company's talc products.

Exxon Mobil Corp., up $2.09 to $60.46.

Energy companies benefited from rising prices for crude oil.

AMC Entertainment Holdings Inc., up $5.92 to $32.04.

The movie theater operator announced a stock sale, raising $230.5 million.

Bank of America Corp., up 53 cents to $42.92.

Bank stocks rose along with bond yields, which allows banks to charge more lucrative interest rates on loans.

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

Stocks mentioned in the article
ChangeLast1st jan.
ABBOTT LABORATORIES -0.74% 124.37 Delayed Quote.13.59%
AMC ENTERTAINMENT HOLDINGS, INC. 0.08% 40.01 Delayed Quote.1,787.26%
CLOUDERA, INC. 0.06% 15.92 Delayed Quote.14.45%
JOHNSON & JOHNSON -0.30% 164.36 Delayed Quote.4.44%
QUANTA SERVICES, INC. -1.11% 117.29 Delayed Quote.62.86%
All news about JOHNSON & JOHNSON
09/24CORONAVIRUS : U.S. Government Donates 336,000 Single-dose Johnson & Johnson Vaccines to Mo..
AQ
09/24JOHNSON & JOHNSON : Pennsylvania Jury Reportedly Finds Johnson & Johnson Baby Power Didn't..
MT
09/24CDC Recommends Booster Shots of Pfizer-BioNTech COVID-19 Vaccine for Older Adults, High..
MT
09/24JOHNSON & JOHNSON : United States Supreme Court Declines To Hear Talcum Powder Appeal
AQ
09/22JOHNSON & JOHNSON : Unit Signs Deal for HealthVerity Patient Data Platform
MT
09/22PRO BANKRUPTCY BRIEFING : J&J Beats Injury Lawyers on Talc Bankruptcy; Judge Questions Tal..
DJ
09/21JOHNSON & JOHNSON : Unit Collaborates With Persephone Biosciences On Stool Analysis
MT
09/21Shangula Rages Against West's Vaccine Nationalism
AQ
09/21Johnson & Johnson Data Shows COVID-19 Booster Shots 94% Effective Against Moderate to S..
MT
09/21Today on Wall Street: Markets at a pivot point
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Financials (USD)
Sales 2021 94 407 M - -
Net income 2021 22 809 M - -
Net Debt 2021 1 880 M - -
P/E ratio 2021 19,0x
Yield 2021 2,54%
Capitalization 433 B 433 B -
EV / Sales 2021 4,60x
EV / Sales 2022 4,39x
Nbr of Employees 134 500
Free-Float 84,3%
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | MarketScreener
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 164,36 $
Average target price 185,83 $
Spread / Average Target 13,1%
EPS Revisions
Managers and Directors
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON4.44%432 675
ROCHE HOLDING AG10.16%321 605
PFIZER, INC.20.05%246 358
NOVO NORDISK A/S50.45%231 485
ELI LILLY AND COMPANY37.22%210 037
ABBVIE INC.-0.07%189 211